title: Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.
authors.forename: Tiffany
authors.initials: T
authors.lastname: Chang
authors.forename: Kimberly
authors.initials: K
authors.lastname: Krisman
authors.forename: Emily Harding
authors.initials: EH
authors.lastname: Theobald
authors.forename: Jin
authors.initials: J
authors.lastname: Xu
authors.forename: Jon
authors.initials: J
authors.lastname: Akutagawa
authors.forename: Jennifer O
authors.initials: JO
authors.lastname: Lauchle
authors.forename: Scott
authors.initials: S
authors.lastname: Kogan
authors.forename: Benjamin S
authors.initials: BS
authors.lastname: Braun
authors.forename: Kevin
authors.initials: K
authors.lastname: Shannon